Growth and syndromes (to include Turner syndrome)

hrp0094p2-277 | Growth and syndromes (to include Turner syndrome)

Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A

hrp0094p2-278 | Growth and syndromes (to include Turner syndrome)

Effects of growth hormone therapy on serum concentrations of IGF-1 in patients with Turner syndrome: High IGF-1 concentrations despite optimal dose?

hrp0094p2-279 | Growth and syndromes (to include Turner syndrome)

The Effect of Hospital Admission and Nutritional Rehabilitation (NR) on Growth and Metabolic abnormalities in adolescent females with severe Anorexia Nervosa (AN)

hrp0094p2-280 | Growth and syndromes (to include Turner syndrome)

Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status

hrp0094p2-281 | Growth and syndromes (to include Turner syndrome)

Endocrinological assessment in patients with fanconi anemia

hrp0094p2-282 | Growth and syndromes (to include Turner syndrome)

Brain-derived neurotrophic factor and matrix metalloproteinases as markers of metabolic status in girls with Turner syndrome.

hrp0094p2-283 | Growth and syndromes (to include Turner syndrome)

Assessment of genetic defects, baseline characteristics and adverse events reported in the Increlex® registry

hrp0094p2-284 | Growth and syndromes (to include Turner syndrome)

Associations between height and health-related quality of life (HRQoL) and functional independence in children with achondroplasia

hrp0094p2-285 | Growth and syndromes (to include Turner syndrome)

COVID 19 impact on Pediatric Endocrinology care – a short story from Romania

hrp0094p2-286 | Growth and syndromes (to include Turner syndrome)

Single nucleotide variations associated with short stature in Baka Pygmies as identified by Whole Exome Sequence (WES)

hrp0094p2-287 | Growth and syndromes (to include Turner syndrome)

Novel LZTR1 mutations in subjects with features of Noonan Syndrome and GH insensitivity negatively regulate GH-induced IGF-I production and hyperactivate GH-induced ERK1/2 activation in response to GH in vitro

hrp0094p2-288 | Growth and syndromes (to include Turner syndrome)

Comorbidities in Turner Syndrome patients controlled in our center since the 80’s

hrp0094p2-289 | Growth and syndromes (to include Turner syndrome)

Familial Mosaic Turner Syndrome with short stature and spontaneous puberty due to a ring X chromosome with distal Xp22.3 and distal Xq26 deletion

hrp0094p2-290 | Growth and syndromes (to include Turner syndrome)

Linear growth response to growth hormone therapy in underweight versus normal-weight children with idiopathic short stature (ISS)

hrp0094p2-291 | Growth and syndromes (to include Turner syndrome)

Linear Growth and Weight gain in Infants with Significant Neonatal Hypoglycemia during the first two years of age: Comparison of infants of Diabetic Mothers (IDM) versus infants of non-diabetic mothers (INDM) with transient hyperinsulinemia (non-ketotic hypoglycemia)

hrp0094p2-292 | Growth and syndromes (to include Turner syndrome)

Timing of infancy-childhood growth spurt in healthy Turkish children

hrp0094p2-293 | Growth and syndromes (to include Turner syndrome)

Effects of GH replacement therapy on body composition and muscle health in children and adolescents with GH deficiency: one-year prospective case-control study.

hrp0094p2-294 | Growth and syndromes (to include Turner syndrome)

The spectrum of the Prader-Willi-like pheno- and genotype

hrp0094p2-295 | Growth and syndromes (to include Turner syndrome)

An Italian survey on GH stimulation tests and their adverse side effects.

hrp0094p2-296 | Growth and syndromes (to include Turner syndrome)

Comparing the efficacy of nutritional supplementation of different caloric concentrations on linear growth and weight gain in late childhood, a longitudinal study.

hrp0094p2-297 | Growth and syndromes (to include Turner syndrome)

The efficacy and safety of recombinant biosimilar growth hormone treatment in children with GHD and SGA: a Czech retrospective national longitudinal study

hrp0094p2-298 | Growth and syndromes (to include Turner syndrome)

A qPCR based approach for rapid detection of Turner Syndrome and its variants

hrp0094p2-299 | Growth and syndromes (to include Turner syndrome)

Case report: Tall stature, obesity and hip dysplasia in Weaver syndrome due to a loss-of-function variant in EHZ2

hrp0094p2-300 | Growth and syndromes (to include Turner syndrome)

Association of Daily Growth Hormone Injection Adherence and Height among Children with Growth Hormone Deficiency

hrp0094p2-301 | Growth and syndromes (to include Turner syndrome)

The evaluation of growth velocity, height, weight, elementary laboratory tests and hormonal function in the patient with Floating-Harbor syndrome treated with growth hormone for 20 months –case report, preliminary report.

hrp0094p2-302 | Growth and syndromes (to include Turner syndrome)

Two Sibling Cases with Growth Hormone Receptor Mutation: Variable Clinical Expressivity in Laron Syndrome

hrp0094p2-303 | Growth and syndromes (to include Turner syndrome)

A literature review of the potency and selectivity of FGFR-selective tyrosine kinase inhibitors, such as infigratinib, in the potential treatment of achondroplasia

hrp0094p2-304 | Growth and syndromes (to include Turner syndrome)

Impact of estrogen therapy on pubertal growth in Turner syndrome

hrp0094p2-305 | Growth and syndromes (to include Turner syndrome)

Anastrozole improves height prediction and near final height as monotherapy or in combination with growth hormone

hrp0094p2-306 | Growth and syndromes (to include Turner syndrome)

Growth hormone deficiency (GHD) with high circulating insulin-like growth factor-1 (IGF-1) in an adolescent with celiac disease: Is it IGF-1 insensitivity?

hrp0094p2-307 | Growth and syndromes (to include Turner syndrome)

Postnatal Linear Growth and Weight Gain in Infants of Diabetic Mothers (IDM) Who Were Born at or Near Term and Had Severe Neonatal Hypoglycemia Without Other Comorbidities.

hrp0094p2-308 | Growth and syndromes (to include Turner syndrome)

Evidence that non-syndromic familial tall stature has an oligogenic origin including ciliary genes

hrp0094p2-309 | Growth and syndromes (to include Turner syndrome)

Early-onset growth hormone treatment in Prader-Willi syndrome attenuates the risk of transition to severe obesity

hrp0094p2-310 | Growth and syndromes (to include Turner syndrome)

Incidental pituitary adenoma detection in two patients affected by Williams Syndrome: only a coincidence?

hrp0094p2-311 | Growth and syndromes (to include Turner syndrome)

Efficacy of recombinant growth hormone therapy in TRPS 1 syndrome coexisting with growth hormone deficiency.

hrp0094p2-312 | Growth and syndromes (to include Turner syndrome)

Results from the Implementation of a Growth Disorders Related Twinning Programme (Partners4Growth) at tertiary pediatric endocrinology clinics

hrp0094p2-313 | Growth and syndromes (to include Turner syndrome)

Co-occurrence of Turner (46,X-ring/45,X0 mosaicism) and Mayer-Rokitansky-Kuster-Hauser Syndromes: a case report

hrp0094p2-314 | Growth and syndromes (to include Turner syndrome)

Shox Gene Pathologies In Children With Short Stature And Madelung Deformity

hrp0094p2-315 | Growth and syndromes (to include Turner syndrome)

Characteristics of Patients with Noonan Syndrome Carrying a PTPN11 Mutation: The Recombinant Growth Hormone Treatment and Long-Term Follow-up

hrp0094p2-316 | Growth and syndromes (to include Turner syndrome)

Determining factors of a good response to treatment with growth hormone for the first 2 years

hrp0094p2-317 | Growth and syndromes (to include Turner syndrome)

Noonan syndrome patients with short stature at a single pediatric endocrinology centre

hrp0094p2-318 | Growth and syndromes (to include Turner syndrome)

Alterations in Metabolic profile and Body Composition in children with Silver Russell syndrome

hrp0094p2-322 | Growth and syndromes (to include Turner syndrome)

Growth abnormalities in patients with Type 1 diabetes

hrp0094p2-323 | Growth and syndromes (to include Turner syndrome)

A novel CEP57 mutation of mosaic variegated aneuploidy syndrome in a Chinese girl: a case report and review of literature

hrp0094p2-324 | Growth and syndromes (to include Turner syndrome)

A Patient with Turner Syndrome (45X/46XX) and Congenital Adrenal Hyperplasia: A Case Report and Literature Review

hrp0094p2-325 | Growth and syndromes (to include Turner syndrome)

Impact of oral nutritional supplements on growth outcomes in underweight children (5: 12 years) with no systemic disease.

hrp0094p2-326 | Growth and syndromes (to include Turner syndrome)

Differential diagnosis of pre- and postnatal short stature revisited: 3-M syndrome

hrp0094p2-327 | Growth and syndromes (to include Turner syndrome)

A case of a Floating-Harbor syndrome in a child with severe short stature.

hrp0094p2-328 | Growth and syndromes (to include Turner syndrome)

Excessive body hair, short stature and advanced bone age in a girl: Hypertrichosis versus adrenarche?

hrp0094p2-329 | Growth and syndromes (to include Turner syndrome)

Cornelia de Lange syndrome: a case report

hrp0094p2-330 | Growth and syndromes (to include Turner syndrome)

Short stature and efficacy of growth hormone treatment in a child with Nail-Patella Syndrome. A case report.

hrp0094p2-331 | Growth and syndromes (to include Turner syndrome)

Final and Near-final Adult Height and BMI after Long-term Growth Hormone Treatment in Patients with Turner Syndrome (TS)

hrp0094p2-332 | Growth and syndromes (to include Turner syndrome)

ESPE Abstracts

59th Annual ESPE (ESPE 2021 Online)

BiosciAbstracts